study

New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-‘749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed

Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with…

4 days ago

EADV Congress 2025: Atopic eczema linked to significantly higher risk of suicidal thoughts

PARIS, Sept. 17, 2025 /PRNewswire/ -- A new international study presented today at the European Academy of Dermatology and Venereology (EADV)…

5 days ago

No Difference in Transplant Outcomes Seen for Patients Unlikely to Find a Matched Unrelated Donor When a Donor Search Prognosis Strategy is Used

Published in the Journal of Clinical Oncology, results showed no difference in any outcomes, including overall survival, at two years…

6 days ago

Novo Nordisks oral semaglutide 25 mg (Wegovy in a pill*) delivered 16.6% weight loss in people with obesity in a newly published study

Oral semaglutide 25 mg (the once-daily pill formulation of Wegovy®) achieved significant weight loss, with one in three study participants…

1 week ago

New Survey Shows AI Has Become a Strategic Imperative for HR: 9 in 10 Leaders Confident in Its Use

Survey of 1,340 HR leaders shows widespread AI use, prioritizing solutions that value employee trustSAN FRANCISCO--(BUSINESS WIRE)--#HealthWayFinding--Transcarent, the One Place…

1 week ago

Metabolon Partners with China Kadoorie Biobank to Advance Precision Health

The landmark multiomics study will examine how lifestyle, environmental, socioeconomic, and genetic factors play a significant role in shaping common…

2 weeks ago

J.S. Held Experts Contribute to the International Valuation Standards Council Report on Intangible Assets in ASEAN Capital Markets

SINGAPORE, Sept. 12, 2025 /PRNewswire/ -- Global consulting firm J.S. Held announces a collaboration between the International Valuation Standards Council (IVSC),…

2 weeks ago

New Bounteous White Paper Maps the AI Whitespace for Business Leaders

Study of 300+ executives identifies misalignment between marketing and IT as key barrier to AI transformation CHICAGO, Sept. 10, 2025…

2 weeks ago

Junshi Biosciences Announces the Phase 3 Study of JS005 (IL-17A) for the Treatment of Moderate to Severe Plaque Psoriasis Met Primary Endpoints

SHANGHAI, Sept. 07, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading…

3 weeks ago

Encaleret Showed Parathyroid Hormone-Independent Normalization of Blood and Urine Calcium in Phase 2 Proof-of-Concept Study in Post-Surgical Hypoparathyroidism

September 06, 2025 14:30 ET  | Source: BridgeBio Pharma, Inc. - 80% of post-surgical hypoparathyroidism participants achieved concomitant blood and…

3 weeks ago